rs28997575

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 2P and 16B. PM4BP6_Very_StrongBA1

The NM_000465.4(BARD1):​c.1075_1095delTTGCCTGAATGTTCTTCACCA​(p.Leu359_Pro365del) variant causes a conservative inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.023 in 1,614,032 control chromosomes in the GnomAD database, including 759 homozygotes. It is difficult to determine the true allele frequency of this variant because it is of type DEL_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. L359L) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.028 ( 85 hom., cov: 32)
Exomes 𝑓: 0.022 ( 674 hom. )

Consequence

BARD1
NM_000465.4 conservative_inframe_deletion

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:18

Conservation

PhyloP100: 2.10

Publications

19 publications found
Variant links:
Genes affected
BARD1 (HGNC:952): (BRCA1 associated RING domain 1) This gene encodes a protein which interacts with the N-terminal region of BRCA1. In addition to its ability to bind BRCA1 in vivo and in vitro, it shares homology with the 2 most conserved regions of BRCA1: the N-terminal RING motif and the C-terminal BRCT domain. The RING motif is a cysteine-rich sequence found in a variety of proteins that regulate cell growth, including the products of tumor suppressor genes and dominant protooncogenes. This protein also contains 3 tandem ankyrin repeats. The BARD1/BRCA1 interaction is disrupted by tumorigenic amino acid substitutions in BRCA1, implying that the formation of a stable complex between these proteins may be an essential aspect of BRCA1 tumor suppression. This protein may be the target of oncogenic mutations in breast or ovarian cancer. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2013]
BARD1 Gene-Disease associations (from GenCC):
  • BARD1-related cancer predisposition
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • breast cancer
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • hereditary breast carcinoma
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • familial ovarian cancer
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

PM4
Nonframeshift variant in NON repetitive region in NM_000465.4.
BP6
Variant 2-214780778-GTGGTGAAGAACATTCAGGCAA-G is Benign according to our data. Variant chr2-214780778-GTGGTGAAGAACATTCAGGCAA-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 140795.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0711 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000465.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BARD1
NM_000465.4
MANE Select
c.1075_1095delTTGCCTGAATGTTCTTCACCAp.Leu359_Pro365del
conservative_inframe_deletion
Exon 4 of 11NP_000456.2Q99728-1
BARD1
NM_001282543.2
c.1018_1038delTTGCCTGAATGTTCTTCACCAp.Leu340_Pro346del
conservative_inframe_deletion
Exon 3 of 10NP_001269472.1Q99728-2
BARD1
NM_001282545.2
c.215+16262_215+16282delTTGCCTGAATGTTCTTCACCA
intron
N/ANP_001269474.1C9IYG1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BARD1
ENST00000260947.9
TSL:1 MANE Select
c.1075_1095delTTGCCTGAATGTTCTTCACCAp.Leu359_Pro365del
conservative_inframe_deletion
Exon 4 of 11ENSP00000260947.4Q99728-1
BARD1
ENST00000617164.5
TSL:1
c.1018_1038delTTGCCTGAATGTTCTTCACCAp.Leu340_Pro346del
conservative_inframe_deletion
Exon 3 of 10ENSP00000480470.1Q99728-2
BARD1
ENST00000613706.5
TSL:1
c.906+169_906+189delTTGCCTGAATGTTCTTCACCA
intron
N/AENSP00000484976.2A0A087X2H0

Frequencies

GnomAD3 genomes
AF:
0.0282
AC:
4294
AN:
152090
Hom.:
85
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0404
Gnomad AMI
AF:
0.0537
Gnomad AMR
AF:
0.0379
Gnomad ASJ
AF:
0.00778
Gnomad EAS
AF:
0.0478
Gnomad SAS
AF:
0.0774
Gnomad FIN
AF:
0.00179
Gnomad MID
AF:
0.0348
Gnomad NFE
AF:
0.0183
Gnomad OTH
AF:
0.0316
GnomAD2 exomes
AF:
0.0289
AC:
7261
AN:
251308
AF XY:
0.0304
show subpopulations
Gnomad AFR exome
AF:
0.0432
Gnomad AMR exome
AF:
0.0337
Gnomad ASJ exome
AF:
0.0120
Gnomad EAS exome
AF:
0.0439
Gnomad FIN exome
AF:
0.00356
Gnomad NFE exome
AF:
0.0179
Gnomad OTH exome
AF:
0.0324
GnomAD4 exome
AF:
0.0224
AC:
32769
AN:
1461824
Hom.:
674
AF XY:
0.0238
AC XY:
17297
AN XY:
727208
show subpopulations
African (AFR)
AF:
0.0432
AC:
1447
AN:
33480
American (AMR)
AF:
0.0340
AC:
1521
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.0120
AC:
313
AN:
26134
East Asian (EAS)
AF:
0.0583
AC:
2312
AN:
39690
South Asian (SAS)
AF:
0.0714
AC:
6162
AN:
86258
European-Finnish (FIN)
AF:
0.00311
AC:
166
AN:
53412
Middle Eastern (MID)
AF:
0.0349
AC:
201
AN:
5766
European-Non Finnish (NFE)
AF:
0.0171
AC:
19005
AN:
1111980
Other (OTH)
AF:
0.0272
AC:
1642
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.429
Heterozygous variant carriers
0
2178
4356
6533
8711
10889
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
802
1604
2406
3208
4010
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0282
AC:
4294
AN:
152208
Hom.:
85
Cov.:
32
AF XY:
0.0284
AC XY:
2112
AN XY:
74426
show subpopulations
African (AFR)
AF:
0.0405
AC:
1681
AN:
41522
American (AMR)
AF:
0.0379
AC:
579
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.00778
AC:
27
AN:
3472
East Asian (EAS)
AF:
0.0477
AC:
247
AN:
5174
South Asian (SAS)
AF:
0.0776
AC:
374
AN:
4818
European-Finnish (FIN)
AF:
0.00179
AC:
19
AN:
10616
Middle Eastern (MID)
AF:
0.0238
AC:
7
AN:
294
European-Non Finnish (NFE)
AF:
0.0183
AC:
1246
AN:
68004
Other (OTH)
AF:
0.0308
AC:
65
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
199
399
598
798
997
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
50
100
150
200
250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00648
Hom.:
13
Bravo
AF:
0.0308
Asia WGS
AF:
0.0570
AC:
196
AN:
3478
EpiCase
AF:
0.0230
EpiControl
AF:
0.0226

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
7
Familial cancer of breast (7)
-
-
4
Hereditary cancer-predisposing syndrome (4)
-
-
4
not specified (4)
-
-
2
not provided (2)
-
-
1
Hereditary breast ovarian cancer syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
2.1
Mutation Taster
=172/28
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs28997575; hg19: chr2-215645502; COSMIC: COSV53608540; COSMIC: COSV53608540; API